| Sub Cat. No. |
Molecular Weight |
Glycan Name |
Functional Group |
Inquiry |
|
X25-05-YM686-1 |
PEG 350 Da |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-2 |
PEG 550 Da |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-3 |
PEG 750 Da |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-4 |
PEG 1 kDa |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-5 |
PEG 2 kDa |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-6 |
PEG 3 kDa |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-7 |
PEG 4 kDa |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-8 |
PEG 5 kDa |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-9 |
PEG 10 kDa |
Lentinan |
DLPE |
Inquiry
|
|
X25-05-YM686-10 |
PEG 20 kDa |
Lentinan |
DLPE |
Inquiry
|
Properties
Description
Lentinan-PEG-DLPE, called DLPE-lentinan, develops a dilauroyl phosphatidylethanolamine-conjugated hybrid through polyethylene glycol spacers bonding phospholipids to lentinan's glucan framework. This membrane-integratable compound maintains helical conformation while enhancing liposome compatibility for immune cell delivery.
Glycan Structure
Its glycan structure is a β-(1→3)-linked d-glucose backbone with β-(1→6)-glucosyl side branches.
Source
Chemical synthesis
Impurities
No visible impurities to the naked eye.
Solubility
This product is soluble in most organic solvents, such as DCM, DMF, DMSO, and THF, and exhibits excellent solubility in water.
Identity
Confirmed by NMR.
Applications
Lentinan-PEG-1,2-dilauroyl-sn-glycero-3-phosphoethanolamine can be used for its potential to enhance tumor targeting through RGD-PEG conjugation in integrin-mediated uptake assays.